Open labelled Non-Interventional Study to assess EffiCacy & tolerability evaluation of PerindOpril-AmlodipiNe fixed dose combinaTion with oR without addition of Diuretics for uncOntrolled hypertensive patients in the cLinical setting, "CONTROL Study"
Phase of Trial: Phase IV
Latest Information Update: 15 Jun 2015
Price : $35 *
At a glance
- Drugs Perindopril/amlodipine (Primary) ; Indapamide
- Indications Essential hypertension
- Focus Adverse reactions; Therapeutic Use
- Acronyms CONTROL
- Sponsors Servier
- 15 Jun 2015 Primary endpoint 'target achievement rate (reduction in blood pressure to target values)' has been met as per the abstract presented at 25th European Meeting on Hypertension and Cardiovascular Protection.
- 15 Jun 2015 Results presented at the 25th European Meeting on Hypertension and Cardiovascular Protection.
- 09 Nov 2013 New trial record